Computational Design of Two New Vitamin K Epoxide Reductase Inhibitors
Abstract
Vitamin K epoxide reductase (VKOR) inhibitors are commonly used to treat atrial fibrillation and ischemic stroke. However, due to the side effects and poor absorbance of existing drugs, there is urgent need for developing better VKOR inhibitor drugs. In this work, computational bioisosteric replacement and chemical intuition were used to design two novel VKOR inhibitors. The new candidates are predicted to have improved ADMET and binding properties compared to existing drugs.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Computational ligands to VKORC1s and CYPs. Could they predict new anticoagulant rodenticides?
A. Bermejo-Nogales, J. M. Navas, J. Coll·bioRxiv·Jan 22, 2021
- Warfarin analogs target disulfide bond-forming enzymes and suggest a residue important for quinone and coumarin binding
Dariana Chavez, Gwendolyn Nita Amarquaye, … Cristina Landeta·Journal of Biological ChemistryPeer-reviewed·May 16, 2024
- Computationally Guided Design of Two Novel Soluble Epoxide Hydrolase Inhibitors
E. C. Dere, S. S. Chu, … J. B. Siegel·bioRxiv·Sep 13, 2022
- De Novo Design of κ-Opioid Receptor Antagonists Using a Generative Deep Learning Framework
Leslie A. Salas-Estrada, Davide Provasi, … Marta Filizola·Journal of Chemical Information and ModelingPeer-reviewed·Aug 9, 2023
- Efficient Hit-to-Lead Searching of Kinase Inhibitor Chemical Space via Computational Fragment Merging
G. V. Andrianov, W. J. G. Ong, … J. Karanicolas·bioRxiv·Jun 1, 2021
- Computational Design of Two Novel BRAF V600E Inhibitors: Exploiting Sulfoximine Bioisosterism and Chiral Constraints to Evade Paradoxical Activation
Zoe Hoi Shuen Yu, Emma R Morrow, Justin B. Siegel·bioRxiv·Jun 30, 2026